Literature DB >> 32315582

Parvovirus Capsid-Antibody Complex Structures Reveal Conservation of Antigenic Epitopes Across the Family.

Shanan N Emmanuel1, Mario Mietzsch1, Yu Shan Tseng1, James Kennon Smith1, Mavis Agbandje-McKenna1.   

Abstract

The parvoviruses are small nonenveloped single stranded DNA viruses that constitute members that range from apathogenic to pathogenic in humans and animals. The infection with a parvovirus results in the generation of antibodies against the viral capsid by the host immune system to eliminate the virus and to prevent re-infection. For members currently either being developed as delivery vectors for gene therapy applications or as oncolytic biologics for tumor therapy, efforts are aimed at combating the detrimental effects of pre-existing or post-treatment antibodies that can eliminate therapeutic benefits. Therefore, understanding antigenic epitopes of parvoviruses can provide crucial information for the development of vaccination applications and engineering novel capsids able to escape antibody recognition. This review aims to capture the information for the binding regions of ∼30 capsid-antibody complex structures of different parvovirus capsids determined to date by cryo-electron microscopy and three-dimensional image reconstruction. The comparison of all complex structures revealed the conservation of antigenic regions among parvoviruses from different genera despite low sequence identity and indicates that the available data can be used across the family for vaccine development and capsid engineering.

Entities:  

Keywords:  binding epitopes; cryo-EM and 3D image reconstruction; neutralizing antibodies; parvoviruses; viral vectors

Mesh:

Substances:

Year:  2020        PMID: 32315582      PMCID: PMC8020512          DOI: 10.1089/vim.2020.0022

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  134 in total

1.  Cloning of a human parvovirus by molecular screening of respiratory tract samples.

Authors:  Tobias Allander; Martti T Tammi; Margareta Eriksson; Annelie Bjerkner; Annika Tiveljung-Lindell; Björn Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-23       Impact factor: 11.205

2.  Identification and mapping of neutralizing epitopes of human parvovirus B19 by using human antibodies.

Authors:  H Sato; J Hirata; N Kuroda; H Shiraki; Y Maeda; K Okochi
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  Mapping a neutralizing epitope onto the capsid of adeno-associated virus serotype 8.

Authors:  Brittney L Gurda; Christina Raupp; Ruth Popa-Wagner; Matthias Naumer; Norman H Olson; Robert Ng; Robert McKenna; Timothy S Baker; Jürgen A Kleinschmidt; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

4.  Different mechanisms of antibody-mediated neutralization of parvoviruses revealed using the Fab fragments of monoclonal antibodies.

Authors:  Christian D S Nelson; Laura M Palermo; Susan L Hafenstein; Colin R Parrish
Journal:  Virology       Date:  2007-01-09       Impact factor: 3.616

5.  Immune responses to the major capsid protein during parvovirus infection of rats.

Authors:  Lisa J Ball-Goodrich; Frank X Paturzo; Elizabeth A Johnson; Krista Steger; Robert O Jacoby
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

6.  Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2.

Authors:  K Qing; C Mah; J Hansen; S Zhou; V Dwarki; A Srivastava
Journal:  Nat Med       Date:  1999-01       Impact factor: 53.440

7.  Structure determination of feline panleukopenia virus empty particles.

Authors:  M Agbandje; R McKenna; M G Rossmann; M L Strassheim; C R Parrish
Journal:  Proteins       Date:  1993-06

8.  Prevalence and clinical aspects of human bocavirus infection in children.

Authors:  L Karalar; J Lindner; S Schimanski; M Kertai; H Segerer; S Modrow
Journal:  Clin Microbiol Infect       Date:  2009-08-04       Impact factor: 8.067

9.  Adeno-associated virus type 12 (AAV12): a novel AAV serotype with sialic acid- and heparan sulfate proteoglycan-independent transduction activity.

Authors:  Michael Schmidt; Antonis Voutetakis; Sandra Afione; Changyu Zheng; Danielle Mandikian; John A Chiorini
Journal:  J Virol       Date:  2007-11-28       Impact factor: 5.103

10.  Intermediates of adeno-associated virus type 2 assembly: identification of soluble complexes containing Rep and Cap proteins.

Authors:  A Wistuba; S Weger; A Kern; J A Kleinschmidt
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

View more
  9 in total

1.  pH-Induced Conformational Changes of Human Bocavirus Capsids.

Authors:  Mengxiao Luo; Mario Mietzsch; Paul Chipman; Kangkang Song; Chen Xu; John Spear; Duncan Sousa; Robert McKenna; Maria Söderlund-Venermo; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2021-01-20       Impact factor: 5.103

2.  Structural Study of Aavrh.10 Receptor and Antibody Interactions.

Authors:  Mario Mietzsch; Jennifer C Yu; Jane Hsi; Paul Chipman; Felix Broecker; Zhang Fuming; Robert J Linhardt; Peter H Seeberger; Regine Heilbronn; Robert McKenna; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2021-09-22       Impact factor: 5.103

Review 3.  Cryo-electron Microscopy of Adeno-associated Virus.

Authors:  Scott M Stagg; Craig Yoshioka; Omar Davulcu; Michael S Chapman
Journal:  Chem Rev       Date:  2022-05-16       Impact factor: 72.087

4.  Characterization of the Serpentine Adeno-Associated Virus (SAAV) Capsid Structure: Receptor Interactions and Antigenicity.

Authors:  Mario Mietzsch; Joshua A Hull; Victoria E Makal; Alberto Jimenez Ybargollin; Jennifer C Yu; Kedrick McKissock; Antonette Bennett; Judit Penzes; Bridget Lins-Austin; Qian Yu; Paul Chipman; Nilakshee Bhattacharya; Duncan Sousa; David Strugatsky; Peter Tijssen; Robert McKenna; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2022-05-09       Impact factor: 6.549

5.  Structurally Mapping Antigenic Epitopes of Adeno-associated Virus 9: Development of Antibody Escape Variants.

Authors:  Shanan N Emmanuel; J Kennon Smith; Jane Hsi; Yu-Shan Tseng; Matias Kaplan; Mario Mietzsch; Paul Chipman; Aravind Asokan; Robert McKenna; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2021-11-10       Impact factor: 6.549

6.  Overcoming Immunological Challenges Limiting Capsid-Mediated Gene Therapy With Machine Learning.

Authors:  Anna Z Wec; Kathy S Lin; Jamie C Kwasnieski; Sam Sinai; Jeff Gerold; Eric D Kelsic
Journal:  Front Immunol       Date:  2021-04-27       Impact factor: 7.561

7.  Coevolution of Adeno-associated Virus Capsid Antigenicity and Tropism through a Structure-Guided Approach.

Authors:  L Patrick Havlik; Katherine E Simon; J Kennon Smith; Kelli A Klinc; Longping V Tse; Daniel K Oh; Marco M Fanous; Rita M Meganck; Mario Mietzsch; Jürgen Kleinschmidt; Mavis Agbandje-McKenna; Aravind Asokan
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

8.  Structural Characterization of Cuta- and Tusavirus: Insight into Protoparvoviruses Capsid Morphology.

Authors:  Mario Mietzsch; Robert McKenna; Elina Väisänen; Jennifer C Yu; Maria Ilyas; Joshua A Hull; Justin Kurian; J Kennon Smith; Paul Chipman; Yi Lasanajak; David Smith; Maria Söderlund-Venermo; Mavis Agbandje-McKenna
Journal:  Viruses       Date:  2020-06-17       Impact factor: 5.048

9.  Completion of the AAV Structural Atlas: Serotype Capsid Structures Reveals Clade-Specific Features.

Authors:  Mario Mietzsch; Ariana Jose; Paul Chipman; Nilakshee Bhattacharya; Nadia Daneshparvar; Robert McKenna; Mavis Agbandje-McKenna
Journal:  Viruses       Date:  2021-01-13       Impact factor: 5.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.